Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TT 702

Next Previous
Drug Profile

TT 702

Alternative Names: TT-702

Latest Information Update: 12 Dec 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Teon Therapeutics
  • Developer Cancer Research UK; Teon Therapeutics
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Adenosine A2B receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Solid tumours
  • Phase I Prostate cancer; Triple negative breast cancer

Most Recent Events

  • 12 Dec 2022 Phase-I clinical trials in Prostate cancer (Hormone refractory, Metastatic disease) in USA (PO) (Teon Therapeutics pipeline, December 2022)
  • 12 Dec 2022 Phase-I clinical trials in Triple-negative-breast-cancer in USA (PO) (Teon Therapeutics pipeline, December 2022)
  • 10 Apr 2021 Teon Therapeutics and Cancer Research UK plans a phase Ib/IIa trial in Solid tumours (late-stage disease) in 2021

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top